SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-075519
Filing Date
2017-12-29
Accepted
2017-12-29 07:30:32
Documents
9
Period of Report
2017-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-28883_18k.htm 8-K 36351
2 EX-10.1 a17-28883_1ex10d1.htm EX-10.1 80466
3 EX-10.2 a17-28883_1ex10d2.htm EX-10.2 89463
4 EX-10.3 a17-28883_1ex10d3.htm EX-10.3 82384
5 EX-10.4 a17-28883_1ex10d4.htm EX-10.4 85021
6 EX-10.5 a17-28883_1ex10d5.htm EX-10.5 88616
7 EX-10.6 a17-28883_1ex10d6.htm EX-10.6 89783
8 EX-10.7 a17-28883_1ex10d7.htm EX-10.7 89406
9 EX-10.8 a17-28883_1ex10d8.htm EX-10.8 89216
  Complete submission text file 0001104659-17-075519.txt   732150
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 171279772
SIC: 2835 In Vitro & In Vivo Diagnostic Substances